Exclusive Interview with Ensemble Therapeutics Ahead of SMi's 2nd Annual Peptides Conference | 8th - 9th July 2015, London, UK

Share Article

SMi’s 2nd annual Peptides conference will be taking place on the 8th & 9th July 2015 at the Marriott Hotel Regents Park in London, UK

News Image
The introduction of nucleic-acid-encoded libraries of peptides/peptidomimetics and the advancement of predictive algorithms to enhance drug-like properties of newly identified hit series have massively impacted the peptides industry

SMi are thrilled to announce that an exclusive interview with Ensemble Therapeutics' SVP Biological Sciences, Stephen Hale, has just been released. Stephen will be speaking on Day 1 of the conference and his presentation entitled 'Libraries of DNA Encoded Peptidic Macrocycles for Drug Discovery' will look at topics such as; large libraries of synthetically-accessible peptidic macrocycles facilitate hit identification; Interrogating encoded libraries is a rapid and massively parallel process and practical applications of Ensemble’s discovery platform.

When asked what new developments have impacted the peptides industry, he said:
“New developments that specifically impact the therapeutic discovery segment of the peptide industry are the introduction of nucleic-acid-encoded libraries of peptides/peptidomimetics and the advancement of predictive algorithms to enhance drug-like properties of newly identified hit series.”

Upon what he thinks attendees will take away from his talk? He commented:
“The attendees should come away with an appreciation that the pairing of both the ability to generate and screen large libraries of macrocyclic peptides has enabled an efficient and productive drug discovery platform. Additionally, that the chemical series identified during the discovery process are amenable to modification toward a drug-like candidate using available medicinal chemical processes.”

To download the full interview, visit http://www.peptidesevent.com/prweb

The 2 day agenda will provide the opportunity for attendees to benefit from networking with a global audience of leading scientists and key decision makers in the Peptides arena. Confirmed attendees include: Novo Nordisk, MHRA, Ipsen Research Laboratories, Bracco Imaging spa, Complix NV, Huazhong University of Science and Technology, plus many more.

Key 2015 speakers include: Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune, Jörg vollmer, CEO, Nexigen, Stephen Hale, SVP Biological Sciences, Ensemble Therapeutics, Dan Teufel, Head of Chemistry, Bicycle Therapeutics, Juan J. diaz-Mochon, Group Leader NANOCHEMBIO research team, Genyo and Renata Zbozien, Research Manager, Haemostatix.

A brochure with a full list of speakers and presentations is available to download online. For further information or to book a place, visit http://www.peptidesevent.com/prweb

For those who are interested in attending there is currently an early bird discount of £100 before the 29th May. For further details contact Frederick Agboletey on +44 (0)20 7827 6070 or email fagboletey(at)smi-online(dot)co(dot)uk

Sponsored by: Bachem & The PolyPeptide Group

2nd annual Peptides conference
8th & 9th July 2015
Marriott Regents Park Hotel, London, UK
http://www.peptidesevent.com/prweb

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Teri Arri
SMi Group Ltd
+44 207 827 6162
Email >
@Pareapp
Follow >
Pareapp

Visit website